Notice of Intent to Sole Source
ID: JA25-01-1692Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Testing Laboratories and Services (541380)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/2e902f7323184c37b139cc95aa34cc61/view
Timeline
    Description

    The Department of Defense, through the Army Medical Research Acquisition Activity, intends to negotiate a sole source contract with Metabolon, Inc. for metabolomics analysis services over a five-year period, valued at approximately $3.96 million. The contract will support the U.S. Army Research Institute of Environmental Medicine by providing essential analyses of biological samples, including urine and blood, which are critical for ongoing and planned research studies. Metabolon is uniquely qualified to fulfill this requirement due to its extensive library of over 4,000 metabolites and advanced analytical capabilities, including ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). Interested firms may express their capability by March 13, 2025, and should contact Kasey Carroll at kasey.l.carroll.civ@health.mil or Jennifer Bassett at jennifer.s.bassett.civ@health.mil for further information.

    Files
    Title
    Posted
    A02 - JA - Sole Source_Metabolon_rev3jsb_redacted.pdf
    The U.S. Army Medical Research Acquisition Activity seeks to establish a sole source IDIQ contract with Metabolon, Inc. for metabolomics analysis services over a five-year period, valued at approximately $3.96 million. This contract is crucial for the U.S. Army Research Institute of Environmental Medicine to conduct necessary analyses on biological samples, including urine and blood, to support ongoing and planned research studies. Metabolon, the only company capable of meeting specific requirements, maintains an extensive library of over 4,000 metabolites and possesses the expertise to accurately identify thousands of small molecules in samples. The justification for this sole-source award cites the inability of other companies to match Metabolon's capabilities demonstrated through previous notices and requests for information. The government considers this approach necessary to maintain scientific integrity and avoid significant costs associated with repeating analyses in different laboratories. The analysis services are fundamental for generating meaningful data essential to the Army’s research protocols, making this procurement crucial for their operations.
    NOI_Sole Source 2.25.pdf
    The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate a sole source contract with Metabolon Inc for analytical services in metabolomics, involving the analysis of human biological samples (blood, urine, saliva, feces, and tissue). This procurement falls under FAR Part 12 for commercial items, with a focus on laboratory analysis capabilities, particularly ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). Key requirements include the ability to detect thousands of metabolites, advanced bioinformatics support, and staff expertise, including PhD-level scientists for data interpretation. Additionally, data analysis services must provide comprehensive biochemical identification, statistical analysis, and a user-friendly web portal for data visualization. The contractor must follow strict quality control and Good Laboratory Practices (GLP). This notice indicates that there is no solicitation for competitive proposals; interested firms can express their capability by March 13, 2025, to a designated contact. The outcome of this effort aims to enhance metabolic research capabilities within USARIEM, supporting valid and accurate data comparisons across studies.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source ‘omics analyses
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), has issued a Special Notice regarding its intent to sole source ‘omics analyses services. The procurement aims to secure specialized research and development services in the life sciences sector, specifically focusing on health-related research and applied analysis. These services are critical for advancing health care solutions and enhancing the understanding of biological systems, which are vital for military health initiatives. Interested parties can reach out to Kasey Carroll at kasey.l.carroll.civ@health.mil or Courtney Piar at courtney.a.piar.civ@health.mil for further information regarding this opportunity.
    Microbial Testing Supplies - Bridge Contract
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Mouse Tissue Proteomics analysis services
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for mouse tissue proteomics analysis services, specifically focusing on mouse liver tissues to support research on exertional heat stroke. The selected contractor will be responsible for conducting comprehensive proteomic analyses, including global proteomics, phospho-proteomics, and ubiquitinated proteomics, utilizing high-resolution liquid chromatography mass spectrometry (LC-MS) and adhering to a four-month performance timeline. This procurement is critical for advancing military research aimed at optimizing warfighter health and performance under extreme environmental conditions. Interested vendors should direct inquiries to Kasey Carroll or Courtney Piar via email, and proposals must be submitted electronically by the specified deadline.
    5-Year UTARNG Lab Services Blanket Purchase Agreement (BPA)
    Buyer not available
    The Department of Defense, through the Utah Army National Guard (UTARNG), is seeking qualified small businesses to establish a 5-Year Blanket Purchase Agreement (BPA) for medical testing and laboratory services. The contractor will be responsible for providing a range of laboratory tests, including blood and urine analyses, metabolic panels, and immunology assays, with a total anticipated award amount of $41.5 million aimed at enhancing medical readiness for military personnel. This procurement is critical for ensuring timely and high-quality medical services that support the health of personnel, reflecting federal priorities for health readiness and small business participation. Interested parties can contact William T. Brown at william.t.brown68.civ@army.mil or by phone at 801-432-4273 for further details.
    Q301--Notice of Intent to Sole Source - Cytogenetic Lab Testing
    Buyer not available
    The Department of Veterans Affairs (VA) intends to negotiate a sole source contract with the University of Wisconsin System State Laboratory of Hygiene for cytogenetic laboratory testing services at the William S. Middleton VA Hospital in Madison, WI. This firm-fixed-price contract, lasting five years, will encompass key services such as specimen preparation, transportation, analytical testing, and reporting, while adhering to safety and quality standards set by the Clinical Laboratory Improvement Amendments (CLIA). The contract is crucial for providing specialized medical testing services that enhance patient care for veterans. Interested parties may submit their capabilities by March 6, 2025, and should direct inquiries to Contract Specialist Donald St. Onge at donald.st.onge@va.gov or by phone at 414-844-4828.
    Notice of Intent to Sole Source: Allergen Extract Supplies
    Buyer not available
    The Department of Defense, specifically the Department of the Army, intends to execute a Sole Source Award for allergen extract supplies to support the United States Army Centralized Allergen Extract Laboratory (USACAEL) at Fort Meade, Maryland. This procurement, valued at approximately $1.8 million, will involve a Firm Fixed Price contract with a performance period from August 16, 2025, to August 15, 2030, and may include a potential 6-month extension. The supplies are critical for managing allergies and food-related health issues, requiring the contractor to meet stringent FDA approval and USP compliance standards while demonstrating the ability to supply at least 98% of the requested allergen extracts. Interested parties should respond to the notice by contacting Alexis Medrano or Catherine-Tehila Johnson via the provided email addresses by the specified deadline.
    Preventive Maintenance Service for Thermo Orbitrap Fusion Lumos Mass Spectrometer System
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking preventive maintenance services for its Thermo Orbitrap Fusion Lumos mass spectrometer system, which is crucial for the Clinical Cancer Metabolism Facility's research activities. The contractor will be responsible for providing all necessary labor, materials, and equipment to maintain the system's functionality, including annual scheduled visits for cleaning, calibration, and testing, as well as emergency services at no additional cost. This procurement is vital for ensuring the accuracy and reliability of data from clinical trials, directly impacting patient care and safety, and is structured as a firm fixed-price order for one year with four optional extensions. Interested parties, particularly small businesses, are encouraged to submit capability statements by March 3, 2025, and can contact David Romley at David.Romley@nih.gov or 240-276-7822 for further information.
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking qualified contractors to provide Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement aims to ensure compliance with College of American Pathologists (CAP) standards while delivering a wide range of laboratory tests, including timely reporting of results within 72 hours of specimen receipt. This contract is crucial for maintaining high-quality healthcare services for U.S. military personnel and their families stationed in Europe. Interested parties should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, with the contract period set from May 2025 to April 2026.
    Maintenance Service_Quant Studio 5 qPCR Instrument
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking a sole source contract for comprehensive maintenance services for the Applied Biosystems QuantStudio 5 qPCR Instrument. The procurement aims to ensure the instrument's operational efficiency and safety in sequencing viral and Rickettsial diseases, necessitating qualified technicians from Life Technologies Corporation, the sole manufacturer authorized to provide such services since 2020. This maintenance is critical for the ongoing functionality of essential medical equipment used by the government, with services including on-site repairs, preventive maintenance every six months, and emergency support. Interested parties can reach out to Shamai Carter at shamai.m.carter.civ@health.mil or Nataki Johnson Lovett at nataki.s.johnsonlovett.civ@health.mil for further details.
    Ambr 250 High Throughput Bioreactor System
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA) and the Army Medical Research Acquisition Activity, is seeking sources for the procurement of an Ambr 250 High Throughput Bioreactor System. This bioreactor is required to support up to 12 simultaneous cultures for both mammalian and microbial cells, with features such as automated aseptic processing, programmable control loops for pH and dissolved oxygen, and compliance with current Good Manufacturing Practices (cGMP) and 21 CFR Part 11 regulations. The system will enhance the capabilities of the Walter Reed Army Institute of Research's Pilot Bioproduction Facility for the production of monoclonal antibodies, aligning with the government's focus on advancing health technologies for military medical readiness. Interested parties should contact Brenda Mena at brenda.i.mena.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further details, with the performance period for the contract expected to run from June 2025 to May 2026.